Norepinephrine use in cardiogenic shock patients is associated with increased 30 day mortality

Lu, X; Wang, X; Gao, YX; Walline, JH; Yu, SY; Ge, ZZ; Qin, MB; Zhu, HD; Li, Y

Li, Y (通讯作者),Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Emergency Dept, State Key Lab Complex Severe & Rare Dis, Beijing 100730, Peoples R China.

ESC HEART FAILURE, 2022; 9 (3): 1875

Abstract

Aims Norepinephrine is recommended as a first-line vasopressor agent in the haemodynamic stabilization of cardiogenic shock. The survival benefit of n......

Full Text Link